BillionToOne
Developer of a molecular counter platform intended to increase the resolution of cell-free DNA testing. The company's pan-cancer tumor-naive oncology test precisely quantifies tumor burden from a blood sample to track response to therapy and its prenatal testi
Operating in biotech & life sciences based in Menlo Park, CA, USA, BillionToOne operates.
Profile
Developer of a molecular counter platform intended to increase the resolution of cell-free DNA testing. The company's pan-cancer tumor-naive oncology test precisely quantifies tumor burden from a blood sample to track response to therapy and its prenatal testing procedure focuses on quantitative biology and statistical learning methods to optimize the signal-to-noise ratio and detect single-gene disorders, enabling expecting mothers to detect disorders such as sickle-cell disease, beta-thalassemia, spinal muscular atrophy, and cystic fibrosis through a simple blood test.
The company sits in the biotech & life sciences segment, where it competes on its core product or service.
The company is recorded as being based in Menlo Park, CA, USA.
Its current recorded stage is Summer 2017.
The company reports a headcount in the 300 range.
Directory analysis
BillionToOne develops a molecular counter platform that enhances the resolution of cell‑free DNA testing. The platform provides a pan‑cancer, tumor‑naïve oncology assay that quantifies tumor burden from a blood sample and a prenatal test that detects single‑gene disorders such as sickle‑cell disease and cystic fibrosis using quantitative biology and statistical learning.
Positioning: The company positions itself within the liquid biopsy and prenatal diagnostics space, offering tools that aim to improve sensitivity and specificity compared to existing cfDNA assays. Its dual focus on oncology and prenatal screening could give it a niche advantage in a competitive diagnostics market.
Note: BillionToOne offers a liquid biopsy platform for both oncology and prenatal single‑gene disorder screening.
Auto-generated directory analysis from public data · updated 2026-10-06 01:05:26. Informational only, not investment advice.
| Sector | BioTech & Life Sciences |
|---|---|
| Headquarters | Menlo Park, CA, USA |
| Country | United States |
| Employees | 300 |
| Stage | Summer 2017 |
Website: www.billiontoone.com
Browse related
Create a free account